
Albion Capital Group
Description
Albion Capital Group LLP is a prominent independent investment manager based in London, United Kingdom, known for its extensive track record in backing innovative companies poised for significant growth and change. The firm manages a substantial portfolio, overseeing over £1.4 billion (approximately $1.78 billion) in capital across various funds, including several Venture Capital Trusts (VCTs). Their investment philosophy centers on providing long-term support to businesses, fostering their development from early to growth stages.
With a strategic focus on specific high-growth sectors, Albion Capital primarily targets opportunities within B2B software, healthcare, and environmental technologies. Within these domains, they seek out companies demonstrating strong potential for market disruption and sustainable expansion. The firm has a rich history of supporting entrepreneurial ventures, having invested in over 200 companies to date, showcasing their deep experience and commitment to the UK's innovation ecosystem.
Albion Capital typically provides initial funding cheques ranging from £2 million to £10 million (approximately $2.54 million to $12.7 million). This substantial initial investment is often complemented by further follow-on funding as companies achieve milestones and require additional capital for scaling. Their approach emphasizes building strong partnerships with management teams, offering not just financial backing but also strategic guidance and operational support to help portfolio companies navigate challenges and capitalize on growth opportunities.
Investor Profile
Albion Capital Group has backed more than 59 startups, with 0 new investments in the last 12 months alone. The firm has led 12 rounds, about 20% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Malaysia.
- Strong thematic focus on Software, Health Care, Developer Platform.
- Typical check size: $2.5M – $12.7M.
Stage Focus
- Series Unknown (85%)
- Seed (7%)
- Series A (3%)
- Post Ipo Equity (3%)
- Series B (2%)
Country Focus
- United Kingdom (81%)
- United States (17%)
- Malaysia (2%)
Industry Focus
- Software
- Health Care
- Developer Platform
- Enterprise
- Medical
- Renewable Energy
- Biotechnology
- Biofuel
- Computer
- Supply Chain Management
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.